ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Trials Underway to Study COVID-19 Impact on Dialysis Patients americanpharmaceuticalreview
August 24, 2020DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., has begun enrollment on two clinical research trials to study how COVID-19 affects people with end stage kidney disease (ESKD) who are currently receiving dialysis.
Pharma Sources Insight January 2025
